End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
2.62 EGP | -0.76% | +0.38% | -16.56% |
May. 19 | Ibnsina Pharma Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
Mar. 03 | Ibnsina Pharma Reports Earnings Results for the Full Year Ended December 31, 2023 | CI |
Sales 2024 * | 36.64B 776M | Sales 2025 * | 46.76B 990M | Capitalization | 2.64B 55.93M |
---|---|---|---|---|---|
Net income 2024 * | 417M 8.83M | Net income 2025 * | 448M 9.49M | EV / Sales 2024 * | 0.17 x |
Net Debt 2024 * | 3.65B 77.27M | Net Debt 2025 * | 3.44B 72.88M | EV / Sales 2025 * | 0.13 x |
P/E ratio 2024 * |
8.73
x | P/E ratio 2025 * |
6.34
x | Employees | 5,500 |
Yield 2024 * |
2.23% | Yield 2025 * |
2.52% | Free-Float | 61.4% |
1 day | -0.76% | ||
1 week | +0.38% | ||
1 month | +7.82% | ||
3 months | -31.05% | ||
6 months | -2.96% | ||
Current year | -16.56% |
Managers | Title | Age | Since |
---|---|---|---|
Chief Executive Officer | - | 00-12-17 | |
Chief Executive Officer | - | 00-12-17 | |
Momen Gomaa
DFI | Director of Finance/CFO | - | - |
Members of the board | Title | Age | Since |
---|---|---|---|
Director/Board Member | - | - | |
Chief Executive Officer | - | 00-12-17 | |
Chief Executive Officer | - | 00-12-17 |
Date | Price | Change | Volume |
---|---|---|---|
24-05-30 | 2.62 | -0.76% | 7,764,956 |
24-05-29 | 2.64 | +0.38% | 13,382,150 |
24-05-28 | 2.63 | -1.13% | 7,871,076 |
24-05-27 | 2.66 | -1.48% | 9,906,766 |
24-05-26 | 2.7 | +3.45% | 13,393,970 |
End-of-day quote Egyptian Exchange, May 29, 2024
More quotesEPS Revisions
Annual profits - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
-16.56% | 55.87M | |
-37.88% | 13.99B | |
-33.12% | 10.67B | |
+12.54% | 6.29B | |
-11.17% | 5.88B | |
+75.00% | 4.96B | |
-3.36% | 4.54B | |
-9.20% | 3.74B | |
-19.40% | 3.16B | |
-12.15% | 2.85B |
- Stock Market
- Equities
- ISPH Stock